IRIS Accounts Production v24.3.2.46 14130004 director 1.6.23 31.5.24 31.5.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh141300042023-05-31141300042024-05-31141300042023-06-012024-05-31141300042022-05-24141300042022-05-252023-05-31141300042023-05-3114130004ns15:EnglandWales2023-06-012024-05-3114130004ns14:PoundSterling2023-06-012024-05-3114130004ns10:Director12023-06-012024-05-3114130004ns10:PrivateLimitedCompanyLtd2023-06-012024-05-3114130004ns10:SmallEntities2023-06-012024-05-3114130004ns10:AuditExempt-NoAccountantsReport2023-06-012024-05-3114130004ns10:SmallCompaniesRegimeForDirectorsReport2023-06-012024-05-3114130004ns10:SmallCompaniesRegimeForAccounts2023-06-012024-05-3114130004ns10:FullAccounts2023-06-012024-05-3114130004ns10:OrdinaryShareClass12023-06-012024-05-3114130004ns10:RegisteredOffice2023-06-012024-05-3114130004ns5:CurrentFinancialInstruments2024-05-3114130004ns5:CurrentFinancialInstruments2023-05-3114130004ns5:ShareCapital2024-05-3114130004ns5:ShareCapital2023-05-3114130004ns5:RetainedEarningsAccumulatedLosses2024-05-3114130004ns5:RetainedEarningsAccumulatedLosses2023-05-3114130004ns10:OrdinaryShareClass12024-05-31
REGISTERED NUMBER: 14130004 (England and Wales)












Kent Eyelid Surgery Ltd

Unaudited Financial Statements for the Year Ended 31 May 2024






Kent Eyelid Surgery Ltd (Registered number: 14130004)






Contents of the Financial Statements
for the Year Ended 31 May 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Kent Eyelid Surgery Ltd

Company Information
for the Year Ended 31 May 2024







DIRECTOR: Dr P M De Magalhaes E Mota





REGISTERED OFFICE: 71-75 Shelton Street
Covent Garden
London
London
WC2H 9JQ





BUSINESS ADDRESS: 2 Potters Close
Ashford
Kent
TN25 4PX





REGISTERED NUMBER: 14130004 (England and Wales)





ACCOUNTANTS: Edwards & Co
Chartered Accountants
Unit 1, Goat Lees
Trinity Road
Ashford
Kent
TN25 4AB

Kent Eyelid Surgery Ltd (Registered number: 14130004)

Statement of Financial Position
31 May 2024

2024 2023
Notes £    £   
CURRENT ASSETS
Cash at bank 13,836 130

CREDITORS
Amounts falling due within one year 4 3,797 1,593
NET CURRENT ASSETS/(LIABILITIES) 10,039 (1,463 )
TOTAL ASSETS LESS CURRENT LIABILITIES 10,039 (1,463 )

CAPITAL AND RESERVES
Called up share capital 5 1 1
Retained earnings 10,038 (1,464 )
SHAREHOLDERS' FUNDS 10,039 (1,463 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 25 February 2025 and were signed by:





Dr P M De Magalhaes E Mota - Director


Kent Eyelid Surgery Ltd (Registered number: 14130004)

Notes to the Financial Statements
for the Year Ended 31 May 2024

1. STATUTORY INFORMATION

Kent Eyelid Surgery Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
At the year end the company had net liabilities of £1,463. The director expects the company to increase revenues and become profitable in the near future. On this basis the director considers it appropriate to prepare the financial statements on the going concern basis.

Income recognition
Income represents the fair value of consideration received or receivable derived from the provision of goods and services to customers during the year (excluding value added tax) and is recognised when the company becomes entitled to it, usually on the rendering of an invoice.

Income is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them.

Financial instruments
The Company enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties.

Basic financial instruments are recognised at amortised cost, with changes recognised in the income statement.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 2,384 -
Other creditors 1,413 1,593
3,797 1,593

Kent Eyelid Surgery Ltd (Registered number: 14130004)

Notes to the Financial Statements - continued
for the Year Ended 31 May 2024

5. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary £1 1 1